GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (NAS:IRMD) » Definitions » Shiller PE Ratio

iRadimed (iRadimed) Shiller PE Ratio : 65.74 (As of May. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is iRadimed Shiller PE Ratio?

As of today (2024-05-05), iRadimed's current share price is $44.70. iRadimed's E10 for the quarter that ended in Dec. 2023 was $0.68. iRadimed's Shiller PE Ratio for today is 65.74.

The historical rank and industry rank for iRadimed's Shiller PE Ratio or its related term are showing as below:

IRMD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 53.42   Med: 65.87   Max: 87.26
Current: 65.51

During the past years, iRadimed's highest Shiller PE Ratio was 87.26. The lowest was 53.42. And the median was 65.87.

IRMD's Shiller PE Ratio is ranked worse than
85.46% of 282 companies
in the Medical Devices & Instruments industry
Industry Median: 27.07 vs IRMD: 65.51

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

iRadimed's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.360. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.68 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


iRadimed Shiller PE Ratio Historical Data

The historical data trend for iRadimed's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRadimed Shiller PE Ratio Chart

iRadimed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 51.26 69.57

iRadimed Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.26 67.82 77.95 67.79 69.57

Competitive Comparison of iRadimed's Shiller PE Ratio

For the Medical Devices subindustry, iRadimed's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRadimed's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where iRadimed's Shiller PE Ratio falls into.



iRadimed Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

iRadimed's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=44.70/0.68
=65.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRadimed's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, iRadimed's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.36/129.4194*129.4194
=0.360

Current CPI (Dec. 2023) = 129.4194.

iRadimed Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.050 99.695 0.065
201406 0.098 100.560 0.126
201409 0.020 100.428 0.026
201412 0.020 99.070 0.026
201503 0.120 99.621 0.156
201506 0.150 100.684 0.193
201509 0.150 100.392 0.193
201512 0.190 99.792 0.246
201603 0.190 100.470 0.245
201606 0.190 101.688 0.242
201609 0.130 101.861 0.165
201612 0.100 101.863 0.127
201703 -0.020 102.862 -0.025
201706 0.030 103.349 0.038
201709 0.020 104.136 0.025
201712 0.020 104.011 0.025
201803 0.070 105.290 0.086
201806 0.110 106.317 0.134
201809 0.200 106.507 0.243
201812 0.140 105.998 0.171
201903 0.150 107.251 0.181
201906 0.170 108.070 0.204
201909 0.200 108.329 0.239
201912 0.260 108.420 0.310
202003 0.140 108.902 0.166
202006 -0.170 108.767 -0.202
202009 0.090 109.815 0.106
202012 0.050 109.897 0.059
202103 0.110 111.754 0.127
202106 0.120 114.631 0.135
202109 0.200 115.734 0.224
202112 0.310 117.630 0.341
202203 0.200 121.301 0.213
202206 0.260 125.017 0.269
202209 0.270 125.227 0.279
202212 0.290 125.222 0.300
202303 0.270 127.348 0.274
202306 0.330 128.729 0.332
202309 0.400 129.860 0.399
202312 0.360 129.419 0.360

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


iRadimed  (NAS:IRMD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


iRadimed Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of iRadimed's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


iRadimed (iRadimed) Business Description

Traded in Other Exchanges
Address
1025 Willa Springs Drive, Winter Springs, FL, USA, 32708
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.
Executives
Roger E. Susi director, 10 percent owner, officer: CEO, President, Chairman C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
James B Hawkins director C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Anthony Vuoto director
Monty K Allen director
Hilda Frederique Scharen-guivel director 440 PALM ISLAND SE, CLEARWATER BEACH FL 33767
John Glenn officer: Chief Financial Officer 7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
Christopher K. Scott officer: CHIEF FINANCIAL OFFICER & SECR C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Brent Johnson officer: Exec. VP. Sales & Marketing 4900 HOPYARD RD, SUITE 210, PLEASITAN CA 94588
Steven M. Nardi officer: VP MANUFACTURING C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Louis S. Waldman officer: CONTROLLER C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Leslie L Mcdonnell director, officer: Chief Exec Officer & Director 1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Francis X. Casey officer: VP OF REG AND QUAL ASSURANCE C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
John K Mccreery officer: Chief Operating Officer IRADIMED CORP, 1025 WILLA SPRINGS BLVD, WINTER SPRINGS FL 32708
Jonathan Kennedy director INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Serge Novovich director C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708

iRadimed (iRadimed) Headlines